# Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis

> **NCT03824912** · PHASE3 · COMPLETED · sponsor: **Encube Ethicals Pvt. Ltd.** · enrollment: 831 (actual)

## Conditions studied

- Tinea Pedis

## Interventions

- **DRUG:** Ketoconazole Cream 2%
- **DRUG:** Ketoconazole Cream 2% (G&W Laboratories Inc.)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03824912
- **Lead sponsor:** Encube Ethicals Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-23
- **Primary completion:** 2019-01-24
- **Final completion:** 2019-01-24
- **Target enrollment:** 831 (ACTUAL)
- **Last updated:** 2019-06-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03824912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03824912, "Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03824912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*